Healthtech Startups

Suki develops AI technology that assists clinicians with administrative tasks and documentation, enabling healthcare providers to focus more on patient care and clinical work.

7 investors

Synapticure provides virtual care services for individuals and families with neurodegenerative conditions, offering access to expert-led care, cutting-edge treatments, clinical trials, and wraparound support across all 50 US states through a network of local partners.

7 investors

Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.

7 investors

Tempo offers a connected home gym system with AI-guided strength training. The platform uses color-coded weights and 3D body scans to track performance and adapt workout plans for individual users.

7 investors

Terra is an API platform that enables apps and developers in fitness, wellness, sleep, and health spaces to connect with wearable devices. The company facilitates real-time data integration from wearables to power personalized consumer experiences.

7 investors

TetraScience provides a Scientific Data and AI Platform that produces AI-native scientific data and lab data management products for scientific research and discovery. The platform serves life sciences organizations seeking to accelerate scientific outcomes through collaborative data infrastructure and AI applications.

7 investors

Thyme Care develops software to enhance care coordination and outcomes for cancer patients. The platform serves oncology practices and healthcare systems managing the cancer patient journey.

7 investors

Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care. It is sold to employers as a benefit to address healthcare cost, complexity, and access for their members.

7 investors

Trexo develops a robotic device that enables children with cerebral palsy and other mobility disabilities to walk independently at home. The device is designed for use by children, parents, and physiotherapists, combining therapeutic function with home accessibility.

7 investors

U.S. Renal Care provides kidney care and dialysis services for people living with kidney disease, operating over 500 dialysis centers and 200+ home programs across 32 U.S. states. The organization also provides administrative services to Satellite Healthcare Inc.

7 investors

Using few-shot learning to design better drug candidates, faster

7 investors

Valera Health provides virtual mental health care for adults and children, connecting patients with vetted in-house providers who develop personalized, data-driven treatment plans. Each patient is supported by a dedicated care coordinator and care team throughout treatment.

7 investors

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

7 investors

Verbal is an AI platform that audits healthcare interactions—including calls, video telemedicine, clinical notes, and chat—to ensure compliance with internal protocols and external standards like TJC and URAC. It serves healthcare organizations seeking real-time and retrospective quality monitoring across patient-facing teams.

7 investors

Verse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.

7 investors

Vida Health delivers personalized, human-centered digital health care addressing both physical and mental health. The company serves health plans, employers, and patients through virtual care, care coordination, and health management solutions.

7 investors

Visby Medical manufactures at-home PCR tests for sexually transmitted infections, providing FDA-authorized results in 30 minutes. The company serves individuals seeking fast, private STI testing without clinical delays, with integrated telehealth access for positive results.

7 investors

Vistapath develops technology solutions to modernize pathology lab operations, helping pathology laboratories improve quality, efficiency, and consistency in critical lab processes.

7 investors

Vitable provides a health benefits platform offering affordable, accessible healthcare to employers and their employees, with a focus on serving everyday workers and low-income populations. The company delivers virtual-first benefits with no copays or deductibles, targeting the 85 million uninsured and underinsured Americans.

7 investors

Vivoo develops at-home urine testing products with machine learning-powered image processing to help users monitor their hydration, nutrition, and overall wellness. The company serves individuals seeking personalized health insights and partners with healthcare professionals to deliver science-backed health monitoring solutions.

7 investors

WavelyDx offers an FDA-listed acoustic scanning device and companion smartphone app that lets parents check their child's ears at home for signs of an ear infection. It uses sound waves bounced off the eardrum to detect fluid and provide a likely/unlikely result, with access to partnered virtual doctors for consults.

7 investors

Welcome Tech provides services and support to help immigrants establish themselves in a new country and navigate life in America. The platform combines community resources and tailored solutions to address the comprehensive needs of immigrants.

7 investors

Wild Earth manufactures plant-based dog food formulated to meet nutritional standards while reducing environmental impact compared to traditional meat-based pet food. The company targets pet owners seeking sustainable, transparent nutrition options for their dogs.

7 investors

Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor. Its products are aimed at patients with multiple autoimmune conditions with unmet medical needs.

7 investors